Evidence map›Paper›PMID 41290572›Full record

ArticleNature communications2025

Organocatalytic iminium-assisted asymmetric B(sp²)-to-B(sp³) transformation.

Yingling Nong, Sai V C Vummaleti, Yili Zhang, Yingzhu Sun, Lingzhu Chen, Zhichao Jin, Huicai Huang, Erhong Hao, Xinglong Zhang, Yonggui Robin Chi

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yingling Nong *State Key Laboratory of Green Pesticide, Guizhou University, Guiyang, China.
Sai V C Vummaleti *Institute of High Performance Computing, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Yili ZhangKey Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
Yingzhu SunKey Laboratory of Functional Molecular Solids, Ministry of Education, School of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui, China.
Lingzhu ChenState Key Laboratory of Green Pesticide, Guizhou University, Guiyang, China.
Zhichao JinState Key Laboratory of Green Pesticide, Guizhou University, Guiyang, China. zcjin@gzu.edu.cn.ORCID http://orcid.org/0000-0003-3003-6437
Huicai HuangKey Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. huanghc@gzucm.edu.cn.ORCID http://orcid.org/0000-0002-8813-1499
Erhong HaoKey Laboratory of Functional Molecular Solids, Ministry of Education, School of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui, China. haoehong@ahnu.edu.cn.ORCID http://orcid.org/0000-0001-7234-4994
Xinglong ZhangInstitute of High Performance Computing, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. xinglong.zhang@cuhk.edu.hk.ORCID http://orcid.org/0000-0003-1698-692X
Yonggui Robin ChiState Key Laboratory of Green Pesticide, Guizhou University, Guiyang, China. robinchi@ntu.edu.sg.ORCID http://orcid.org/0000-0003-0573-257X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tetracoordinate boron compounds are widely used as dyes in medicinal research and material sciences. Current methods for accessing such compounds with a stereogenic boron center rely on chiral substrate-induced diastereoselective reactions or metal-catalyzed desymmetrization of pre-formed tetracoordinate boron molecules. Directly constructing a tetracoordinate B(sp

Identifiers

PMID41290572
PMCPMC12647797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.